Screening of 11,552 Compounds Identifies Innovation Pharmaceuticals’ Brilacidin as One of the Most Promising Potential Inhibitors of the Novel Coronavirus COVID-19

    NEXT STORY
    MERIT MEDICAL SYSTEMS DESIGNS AND PRODUCES SAMPLE COLLECTION AND TRANSPORT KIT
    PREV STORY
    Authentic Heroes To Supply Personal Protective Equipment To Front Line Service Providers
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Accurate Health Care Announces Opening of Third Location in Deland

    NEW SMYRNA, Fla, Feb. 28, 2016 (GLOBE NEWSWIRE) -- Dr. Jake Stiteler, owner of ...

    author_avatar
    NASDAQ Market News

    Scott+Scott, Attorneys at Law, LLP Announces Investigation of Sarepta Therapeutics, Inc.

    NEW YORK, March 28, 2017 (GLOBE NEWSWIRE) -- Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), ...

    author_avatar
    NASDAQ Market News

    MannKind Expands Its Pipeline with the Acquisition of QrumPharma, Inc.

    author_avatar
    NASDAQ Market News